InsidersTradesSigma
BioSyent Inc. Stock: price and management transactions · Canada · SEDI
Follow the BioSyent Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on CA CA, under the authority of SEDI. Operating in the Health Care sector, BioSyent Inc. has published 46 public disclosures. Market capitalisation: €164.3m. The latest transaction was filed on 3 July 2026 (57 - Exercise of rights). Among the most active insiders: Ashrafi, Seyed Ahmad. Every trade is free.
46
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
38Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,449 of 26,134 companies
74.3
score / 100
Value59
Quality90
FCF yld5.2%
Earn yld5.4%
EV/EBITDA12.9x
ROE22%
Gross mgn77%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations46 total
188 shares@ CA$14.500.0017% mcap100.0% of flowRightsTSXSEDI:4745288
376 sharesRightsTSXSEDI:4745284
RightsTSXSEDI:4745275
29,556 sharesRightsTSXSEDI:4743562
11,359 sharesRightsTSXSEDI:4743557
2,170 shares@ CA$14.500.012% mcap100.0% of flowRightsTSXSEDI:4743549
4,340 sharesRightsTSXSEDI:4743543
746 shares@ CA$14.500.0040% mcap18.6% of flowCommon SharesTSXSEDI:4742292
1,493 sharesRightsTSXSEDI:4742290
344 shares@ CA$14.500.0018% mcap100.0% of flowCommon SharesTSXSEDI:4742211
689 sharesRights Restricted Share UnitsTSXSEDI:4742210
600 shares@ CA$14.500.0032% mcap4.6% of flowCommon SharesTSXSEDI:4742118
800 shares@ CA$14.700.0044% mcap6.2% of flowCommon SharesTSXSEDI:4742116
1,884 shares@ CA$14.650.010% mcap14.6% of flowCommon SharesTSXSEDI:4742113
200 shares@ CA$14.600.0011% mcap2.1% of flowCommon SharesTSXSEDI:4741551
548 shares@ CA$14.40090.0031% mcap5.6% of flowCommon SharesTSXSEDI:4741549
200 shares@ CA$14.650.0011% mcap2.1% of flowCommon SharesTSXSEDI:4741546
500 shares@ CA$14.400.0028% mcap5.1% of flowCommon SharesTSXSEDI:4741545
500 shares@ CA$14.3110.0028% mcap5.1% of flowCommon SharesTSXSEDI:4741541
2,000 shares@ CA$14.500.011% mcap20.7% of flowCommon SharesTSXSEDI:4741538
855 shares@ CA$14.06610.0047% mcap8.6% of flowCommon SharesTSXSEDI:4741534
1,000 shares@ CA$14.050.0055% mcap10.0% of flowCommon SharesTSXSEDI:4741533
100 shares@ CA$14.100.0005% mcap1.0% of flowCommon SharesTSXSEDI:4741532
▲
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
5,525 shares@ CA$13.900.030% mcap42.0% of flowCommon SharesTSXSEDI:4740955
Ideal exit: 20 Mar 2027 (T+270)
◇
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
8,557 shares@ CA$6.200.021% mcap29.0% of flowCommon SharesTSXSEDI:4740953
25 of 46 declarations
About BioSyent Inc.
BioSyent Inc. is a Canadian company focused on the development and commercialization of pharmaceutical products. It aims to provide innovative solutions to enhance patient health.